Show items per page
Elements: 17
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique? Mongin, Denis; Lauper, Kim; Turesson, Carl; Hetland, Merete Lund; ... Courvoisier, Delphine 2019
add to browser selection
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Kristianslund, Eirik K; ... Gabay, Cem 2019
add to browser selection
Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution Lauper, Kim; Mongin, Denis; Alpizar Rodriguez, Deshire; Codreanu, Catalin; ... Courvoisier, Delphine 2019
add to browser selection
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration Lauper, Kim; Nordström, Dan C; Pavelka, Karel; Hernández, Maria Victoria; ... Gabay, Cem 2018
add to browser selection
Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider Unger, Julia; Putrik, Polina; Buttgereit, Frank; Aletaha, Daniel; ... Ramiro, Sofia 2018
add to browser selection
EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology Dejaco, Christian; Putrik, Polina; Unger, Julia; Aletaha, Daniel; ... Buttgereit, Frank 2018
add to browser selection
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Klami Kristianslund, Eirik; ... Gabay, Cem 2018
add to browser selection
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Lukina, Galina; Hetland, Merete L; ... van Vollenhoven, Ronald 2017
add to browser selection
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study Gabay, Cem; Riek, Myriam; Hetland, Merete Lund; Hauge, Ellen-Margrethe; ... Kvien, Tore K 2016
add to browser selection
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2016
add to browser selection
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative Baillet, Athan; Gossec, Laure; Carmona, Loreto; Wit, Maarten de; ... Dougados, Maxime 2016
add to browser selection
The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers Kearsley-Fleet, Lianne; Závada, Jakub; Hetland, Merete Lund; Nordström, Dan C; ... Hyrich, Kimme L 2015
add to browser selection
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement Schoels, Monika M; van der Heijde, Désirée; Breedveld, Ferdinand C; Burmester, Gerd R; ... Smolen, Josef S 2013
add to browser selection
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions Smolen, Josef S; Schoels, Monika M; Nishimoto, Norihiro; Breedveld, Ferdinand C; ... van der Heijde, Désirée 2013
add to browser selection
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis Gerlag, Danielle M; Raza, Karim; van Baarsen, Lisa G M; Brouwer, Elisabeth; ... Tak, Paul P 2012
add to browser selection
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... Gabay, Cem 2012
add to browser selection
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2011